Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PIK3CD-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
UBQLN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TLN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
PADI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASGRF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIMS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SERPINB12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CA5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCTD18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTBP1-AS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC14L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCNMB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPRR4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on